Effect of Brihatyadi Upanaha Sweda in the Management of Janu Sandhigatavata

Single Arm Clinical study to access the Efficacy of Brihatyadi Upanaha Sweda in the Management of Janu Sandhigatavata - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080779

Enrollment

Registered

2025-02-18

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients in age group of 50 to 70 years. 2. Patients satisfying the diagnostic criteria. needed for diagnosis of Janu Sandhigatavata. 3. Suitable patients for Swedana theraphy.

Exclusion criteria

Exclusion criteria: 1. Patient with k/c/o Amavata, Vatarakta. 2. Patient with k/c/o Auto immune disease i.e., Ankylosing Spondylitis. 3. Patient with total knee joint replacement. 4. Patient having skin allergies/disease.

Design outcomes

Primary

Measure	Time frame
To assess the effect of Brihatyadi Upanaha Sweda in the management of Janu Sandhigatavata.Timepoint: 21 Days	—

Secondary

Measure	Time frame
1) To study Sandhigatavata in detail as per Ayurvedic aspect. 2) To study the role of Upanaha Sweda in Janu Sandhigatavata in detail. 3) To study probable mode of action of Upanaha Sweda, its effect & adverse effect if any.Timepoint: 12 Months	—

Countries

India

Contacts

Public ContactDr Sonal Shah

LRP Ayurvedic Medical College and Hospital PG Institute and Research Center Urun Islampur, Sangli

drsonalshah2014@gmail.com7972759476

Outcome results